Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Grossbard"'
Autor:
Daniel Freeman, Catherine Diefenbach, Linda Lam, Tri Le, Jason Alexandre, Bruce Raphael, Michael Grossbard, David Kaminetzky, Jia Ruan, Pratip K. Chattopadhyay
Publikováno v:
Cell Reports, Vol 43, Iss 8, Pp 114605- (2024)
Summary: Immune cells express an incredible variety of proteins; by measuring combinations of these, cell types influencing disease can be precisely identified. We developed terraFlow, a platform that defines cell subsets exhaustively by combinatoria
Externí odkaz:
https://doaj.org/article/4552513b2fa146f4b556f6d1f3966949
Publikováno v:
Clinical lung cancer. 11(6)
For many years, the cornerstone of treatment for non-small-cell lung cancer (NSCLC) has been third-generation platinum-based chemotherapy. Unfortunately, clinical outcomes with the use of this approach have remained poor, with median survival times o
Autor:
Adam J. Olszewski, Michael Grossbard
Publikováno v:
Science's STKE. 2004
Rituximab, a monoclonal antibody directed against the B cell–specific protein CD20, has revolutionized lymphoma treatment by providing a highly effective form of therapy with relatively mild toxic side effects. Effective as a single agent against s
Publikováno v:
Blood. 122:4761-4761
Background Anti-Rh(D) has appeal for use in immune thrombocytopenia (ITP) due its rapid onset of action (24 hours) and short infusion time (10 minutes). There is reluctance by some physicians to use anti-Rh(D), however, following FDA reports in 2000
Autor:
Noah, Choi, Thomas, Lynch, Douglas, Mathisen, John, Wain, Cameron, Wright, Robert, Carey, Michael, Grossbard, Hermes, Grillo
Publikováno v:
In International Journal of Radiation Oncology, Biology, Physics 1997 39(2) Supplement 1:203-203